Integrative discovery and targeted proteomics elucidate the plasma exosomal landscape in thyroid disorders, with emphasis on papillary thyroid carcinoma complicating Hashimoto’s thyroiditis - Report - MDSpire
Advertisement
Integrative discovery and targeted proteomics elucidate the plasma exosomal landscape in thyroid disorders, with emphasis on papillary thyroid carcinoma complicating Hashimoto’s thyroiditis
Clinical Report: Plasma Exosomal Profile in Thyroid Disorders and PTC
Overview
This study identifies plasma-derived exosomal biomarkers associated with papillary thyroid carcinoma (PTC) in patients with Hashimoto’s thyroiditis (HT). Notably, SVEP1 and IGKV3-7 were found to be differentially expressed, suggesting their potential as non-invasive diagnostic markers.
Background
Thyroid cancer is the most common endocrine malignancy, with PTC being the predominant type. HT is frequently associated with PTC, and understanding the biomarkers involved in this relationship is crucial for early diagnosis and management. Exosomes, as carriers of various biomolecules, may provide insights into the pathophysiology of these conditions and serve as potential diagnostic tools.
Data Highlights
Group
Number of Patients
PTC
3
PTC with HT
3
HT
3
Healthy Controls
3
Key Findings
A total of 45 differentially expressed proteins (DEPs) were identified between PTC with HT and HT alone.
DEPs were primarily involved in extracellular matrix-receptor interactions and immune response pathways.
SVEP1 and IGKV3-7 showed consistent expression levels across discovery and validation phases.
Exosomal proteins may serve as novel biomarkers for the early diagnosis of PTC in patients with HT.
Current research on exosomes in thyroid diseases is limited, highlighting a gap in understanding their role in PTC.
Clinical Implications
The identification of SVEP1 and IGKV3-7 as biomarkers could facilitate non-invasive diagnostic approaches for PTC in patients with HT. Clinicians should consider the potential of exosomal proteins in risk stratification and early detection of thyroid malignancies.
Conclusion
This study underscores the importance of exosomal proteins in understanding the link between HT and PTC, paving the way for future research into their clinical applications as biomarkers.
